- Among the world’s 20 fastest growing retailers, Amazon just ranks at No. 4 (USA Today)
- Regeneron says FDA approves EYLEA injection for diabetic retinopathy (TheFly)
- No easy options for China as trade war, U.S. pressure bite (Reuters)
- Four reasons why the bears are wrong about a second-half slump: J.P. Morgan (MarketWatch)
- Alibaba’s stock surges after earnings and revenue rise, beat FactSet expectations (MarketWatch)